Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating isotretinoin versus excimer light as adjuvant therapy for onychomycosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Excimer light therapy
  • ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Zagazig University | Conditions: Onychomycosis | Phase 1 | Status: RECRUITING